Bumetanide Dibenzylamide

N/A

Report date: 2025/05/30 11:45:51
NME

Base Information

Drug NameBumetanide Dibenzylamide
Drug Alias Namebumetanide analogNPT-2042NTP-2008
ClassificationSmall molecules
Mechanisms of ActionSolute carrier family 12 member 2 antagonists
TargetsSolute carrier family 12 member 2
Therapy Area/IndicationsEpilepsy, ReflexEpilepsy, AbsenceEpilepsy, Generalized +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuroPro Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroPro Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy, ReflexEpilepsy, AbsenceEpilepsy, Generalized +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A